A Study of CT0596 in Relapsed/Refractory Multiple Myeloma and Relapsed/ Refractory Plasma Cell Leukemia — StellaEarly Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.
Trial locations(1 site)
China
The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu Age range
18 Years and older
Last updated October 2025